Literature DB >> 12147238

Modulation of hypothalamic hypocretin/orexin mRNA expression by glucocorticoids.

Alain Stricker-Krongrad1, Bernard Beck.   

Abstract

The orexins are peptides which were recently isolated from the rat hypothlamus. They play a role in energy homeostasis and regulation of feeding as well as in other functions such as the sleep-wake cycle. The involvement of glucocorticoids in stress processes as well as in body weight regulation is well known. In the present paper, we investigated the role of glucocorticoids on hypocretin (Hcrt)/orexin (OX) pathway in Sprague-Dawley rats. We confirmed by in situ hybridization that prepro-Hcrt/OX mRNA expression is restricted to the lateral hypothalamus area with extension to the perifornical nucleus and the posterior hypothalamic area. Lateral hypothalamic prepro-Hcrt/OX mRNA expression was decreased by 50% after adrenalectomy (99.8+/-5.0 vs 49.2+/-4.4 nCi/g, p<0.01). Peripheral glucocorticoid treatment (dexamethasone) restored its expression to normal levels (105.4+/-6.1 nCi/g). The present data provide direct evidence that Hcrt/OX expression in the lateral hypothalamus is modulated by the glucocorticoids status. As the Hcrt/Ox system is closely interactive with the corticotropin-releasing hormone and neuropeptide Y systems, we propose that hypocretin/orexins peptides constitute a very sensitive key relay for mediating both stress and feeding behavior.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147238     DOI: 10.1016/s0006-291x(02)00848-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

Review 2.  Addiction and arousal: the hypocretin connection.

Authors:  Benjamin Boutrel; Luis de Lecea
Journal:  Physiol Behav       Date:  2007-11-22

3.  Exploring the involvement of Tac2 in the mouse hippocampal stress response through gene networking.

Authors:  Mike Hook; Fuyi Xu; Elena Terenina; Wenyuan Zhao; Athena Starlard-Davenport; Pierre Mormede; Byron C Jones; Megan K Mulligan; Lu Lu
Journal:  Gene       Date:  2019-02-12       Impact factor: 3.688

4.  Corticosterone regulates synaptic input organization of POMC and NPY/AgRP neurons in adult mice.

Authors:  Erika Gyengesi; Zhong-Wu Liu; Giuseppe D'Agostino; Geliang Gan; Tamas L Horvath; Xiao-Bing Gao; Sabrina Diano
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

Review 5.  Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.

Authors:  Raphaëlle Winsky-Sommerer; Benjamin Boutrel; Luis de Lecea
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

6.  Expression and localization of the orexin-1 receptor (OX1R) after traumatic brain injury in mice.

Authors:  Yuko Mihara; Kenji Dohi; Sachiko Yofu; Tomoya Nakamachi; Hirokazu Ohtaki; Seiji Shioda; Tohru Aruga
Journal:  J Mol Neurosci       Date:  2010-08-28       Impact factor: 3.444

7.  Effect of intestinal ischemia-reperfusion injury on protein levels of leptin and orexin-A in peripheral blood and central secretory tissues.

Authors:  Ji Lin; Guang-Tao Yan; Xiu-Hua Hao; Lu-Huan Wang; Kai Zhang; Hui Xue
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

8.  Effect of intestinal ischemia/reperfusion injury on leptin and orexin-A levels.

Authors:  Ji Lin; Guangtao Yan; Xiaoning Gao; Jie Liao; Xiuhua Hao; Kai Zhang
Journal:  Front Med China       Date:  2007-02

9.  Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys.

Authors:  Jamie M Zeitzer; Christine L Buckmaster; David M Lyons; Emmanuel Mignot
Journal:  J Physiol       Date:  2004-04-23       Impact factor: 5.182

Review 10.  A neuropeptide-centric view of psychostimulant addiction.

Authors:  B Boutrel
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.